Dr Andrew Care from the Department of Molecular Sciences has been awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
Andrew’s fellowship will fund research looking at how biological nanoparticles can be used to better deliver anti-cancer drugs to destroy tumours.
Andrew and his team are re-engineering protein-based nanoparticles that are normally found in microorganisms, like bacteria. These re-engineered nanoparticles will be capable of carrying anti-cancer drugs to tumours inside the body. Continue reading Using nanoparticles to better target cancer tumours